|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Zhang B, Liu ZY, Li YY, et al:
Antiinflammatory effects of matrine in LPS-induced acute lung
injury in mice. Eur J Pharm Sci. 44:573–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu JY, Hu JH, Zhu QG, Li FQ, Wang J and
Sun HJ: Effect of matrine on the expression of substance P receptor
and inflammatory cytokines production in human skin keratinocytes
and fibroblasts. Int Immunopharmacol. 7:816–823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suo Z, Liu Y, Ferreri M, et al: Impact of
matrine on inflammation related factors in rat intestinal
microvascular endothelial cells. J Ethnopharmacol. 125:404–409.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li CQ, Zhu YT, Zhang FX, et al: Anti-HBV
effect of liposome-encapsulated matrine in vitro and in vivo. World
J Gastroenterol. 11:426–428. 2005.PubMed/NCBI
|
|
6
|
Long Y, Lin XT, Zeng KL and Zhang L:
Efficacy of intramuscular matrine in the treatment of chronic
hepatitis B. Hepatobiliary Pancreat Dis Int. 3:69–72.
2004.PubMed/NCBI
|
|
7
|
Zhang JP, Zhang M, Zhou JP, et al:
Antifibrotic effects of matrine on in vitro and in vivo models of
liver fibrosis in rats. Acta Pharmacol Sin. 22:183–186.
2001.PubMed/NCBI
|
|
8
|
Zhang JP, Zhang M, Jin C, et al: Matrine
inhibits production and actions of fibrogenic cytokines released by
mouse peritoneal macrophages. Acta Pharmacol Sin. 22:765–768.
2001.PubMed/NCBI
|
|
9
|
Yin LL and Zhu XZ: The involvement of
central cholinergic system in (+)-matrine-induced antinociception
in mice. Pharmacol Biochem Behav. 80:419–425. 2005.
|
|
10
|
Li X, Chu W, Liu J, et al: Antiarrhythmic
properties of long-term treatment with matrine in arrhythmic rat
induced by coronary ligation. Biol Pharm Bull. 32:1521–1526. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou Y, Xu W, Han R, et al: Matrine
inhibits pacing induced atrial fibrillation by modulating I(KM3)
and I(Ca-L). Int J Biol Sci. 8:150–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Wang S, Li Y, Xiao Z, Hu Z and
Zhang J: Sophocarpine and matrine inhibit the production of
TNF-alpha and IL-6 in murine macrophages and prevent
cachexia-related symptoms induced by colon26 adenocarcinoma in
mice. Int Immunopharmacol. 8:1767–1772. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Z, Wang X, Wu W, et al: Effects of
matrine on proliferation and apoptosis in gallbladder carcinoma
cells (GBC-SD). Phytother Res. 26:932–937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Li Y, Chen X, et al: Autophagy is
involved in anticancer effects of matrine on SGC-7901 human gastric
cancer cells. Oncol Rep. 26:115–124. 2011.PubMed/NCBI
|
|
15
|
Zhang JQ, Li YM, Liu T, et al: Antitumor
effect of matrine in human hepatoma G2 cells by inducing apoptosis
and autophagy. World J Gastroenterol. 16:4281–4290. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu T, Song Y, Chen H, Pan S and Sun X:
Matrine inhibits proliferation and induces apoptosis of pancreatic
cancer cells in vitro and in vivo. Biol Pharm Bull. 33:1740–1745.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin XG, Hua Z, Shuang W, Wang YH and Cui
YD: Effects of matrine on HepG2 cell proliferation and expression
of tumor relevant proteins in vitro. Pharm Biol. 48:275–281. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang LP, Jiang JK, Tam JW, et al: Effects
of Matrine on proliferation and differentiation in K-562 cells.
Leuk Res. 25:793–800. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang H, Hou C, Zhang S, et al: Matrine
upregulates the cell cycle protein E2F-1 and triggers apoptosis via
the mitochondrial pathway in K562 cells. Eur J Pharmacol.
559:98–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo C, Zhu Y, Jiang T, et al: Matrine
induced gastric cancer MKN45 cells apoptosis via increasing
pro-apoptotic molecules of Bcl-2 family. Toxicology. 229:245–252.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai ZJ, Gao J, Ji ZZ, et al: Matrine
induces apoptosis in gastric carcinoma cells via alteration of
Fas/FasL and activation of caspase-3. J Ethnopharmacol. 123:91–96.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Zhang J, Chen X, et al: Molecular
machinery of autophagy and its implication in cancer. Am J Med Sci.
343:155–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Apel A, Zentgraf H, Buchler MW and Herr I:
Autophagy-A double-edged sword in oncology. Int J Cancer.
125:991–995. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hippert MM, O’Toole PS and Thorburn A:
Autophagy in cancer: good, bad, or both? Cancer Res. 66:9349–9351.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mathew R, Kongara S, Beaudoin B, et al:
Autophagy suppresses tumor progression by limiting chromosomal
instability. Genes Dev. 21:1367–1381. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Degenhardt K, Mathew R, Beaudoin B, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
28
|
Kondo Y and Kondo S: Autophagy and cancer
therapy. Autophagy. 2:85–90. 2006. View Article : Google Scholar
|
|
29
|
Eisenberg-Lerner A and Kimchi A: The
paradox of autophagy and its implication in cancer etiology and
therapy. Apoptosis. 14:376–391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Z and Klionsky DJ: Mammalian
autophagy: core molecular machinery and signaling regulation. Curr
Opin Cell Biol. 22:124–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gozuacik D and Kimchi A: Autophagy and
cell death. Curr Top Dev Biol. 78:217–245. 2007. View Article : Google Scholar
|
|
33
|
Sun Y and Peng ZL: Programmed cell death
and cancer. Postgrad Med J. 85:134–140. 2009. View Article : Google Scholar
|
|
34
|
Marx J: Autophagy: is it cancer’s friend
or foe? Science. 312:1160–1161. 2006.
|
|
35
|
Yang Z and Klionsky DJ: An overview of the
molecular mechanism of autophagy. Curr Top Microbiol Immunol.
335:1–32. 2009.PubMed/NCBI
|
|
36
|
Glick D, Barth S and Macleod KF:
Autophagy: cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang N, Feng Y, Zhu M, et al: Berberine
induces autophagic cell death and mitochondrial apoptosis in liver
cancer cells: the cellular mechanism. J Cell Biochem.
111:1426–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Le XF, Mao W, Lu Z, Carter BZ and Bast RC
Jr: Dasatinib induces autophagic cell death in human ovarian
cancer. Cancer. 116:4980–4990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mujumdar N, Mackenzie TN, Dudeja V, et al:
Triptolide induces cell death in pancreatic cancer cells by
apoptotic and autophagic pathways. Gastroenterology. 139:598–608.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vucicevic L, Misirkic M, Janjetovic K, et
al: Compound C induces protective autophagy in cancer cells through
AMPK inhibition-independent blockade of Akt/mTOR pathway.
Autophagy. 7:40–50. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang K, Liu R, Li J, et al: Quercetin
induces protective autophagy in gastric cancer cells: involvement
of Akt-mTOR- and hypoxia-induced factor 1alpha-mediated signaling.
Autophagy. 7:966–978. 2011. View Article : Google Scholar
|
|
42
|
Skehan P, Storeng R, Scudiero D, et al:
New colorimetric cytotoxicity assay for anticancer-drug screening.
J Natl Cancer Inst. 82:1107–1112. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Klionsky DJ, Abeliovich H, Agostinis P, et
al: Guidelines for the use and interpretation of assays for
monitoring autophagy in higher eukaryotes. Autophagy. 4:151–175.
2008. View Article : Google Scholar
|
|
44
|
Klionsky DJ, Baehrecke EH, Brumell JH, et
al: A comprehensive glossary of autophagy-related molecules and
processes (2nd edition). Autophagy. 7:1273–1294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu YT, Tan HL, Shui G, et al: Dual role of
3-methyladenine in modulation of autophagy via different temporal
patterns of inhibition on class I and III phosphoinositide
3-kinase. J Biol Chem. 285:10850–10861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Periyasamy-Thandavan S, Jiang M, Wei Q,
Smith R, Yin XM and Dong Z: Autophagy is cytoprotective during
cisplatin injury of renal proximal tubular cells. Kidney Int.
74:631–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen SY, Chiu LY, Maa MC, Wang JS, Chien
CL and Lin WW: zVAD-induced autophagic cell death requires
c-Src-dependent ERK and JNK activation and reactive oxygen species
generation. Autophagy. 7:217–228. 2011. View Article : Google Scholar
|
|
48
|
Hotchkiss RS, Strasser A, McDunn JE and
Swanson PE: Cell death. N Engl J Med. 361:1570–1583. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Scarlatti F, Granata R, Meijer AJ and
Codogno P: Does autophagy have a license to kill mammalian cells?
Cell Death Differ. 16:12–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Levine B and Yuan J: Autophagy in cell
death: an innocent convict? J Clin Invest. 115:2679–2688. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Coughlin CM, Johnston DS, Strahs A, et al:
Approaches and limitations of phosphatidylinositol-3-kinase pathway
activation status as a predictive biomarker in the clinical
development of targeted therapy. Breast Cancer Res Treat. 124:1–11.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
O’Reilly KE, Rojo F, She QB, et al: mTOR
inhibition induces upstream receptor tyrosine kinase signaling and
activates Akt. Cancer Res. 66:1500–1508. 2006.PubMed/NCBI
|
|
53
|
Guertin DA and Sabatini DM: Defining the
role of mTOR in cancer. Cancer Cell. 12:9–22. 2007. View Article : Google Scholar
|
|
54
|
Zhao B, Li B, Bai S, et al: Effects of
matrine on proliferation and apoptosis of cultured retinoblastoma
cells. Graefes Arch Clin Exp Ophthalmol. 250:897–905. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Han Y, Zhang S, Wu J, et al: Matrine
induces apoptosis of human multiple myeloma cells via activation of
the mitochondrial pathway. Leuk Lymphoma. 51:1337–1346. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ
and Tao HM: Matrine induces caspase-dependent apoptosis in human
osteosarcoma cells in vitro and in vivo through the upregulation of
Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother
Pharmacol. 69:317–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ma L, Wen S, Zhan Y, He Y, Liu X and Jiang
J: Anticancer effects of the Chinese medicine matrine on murine
hepatocellular carcinoma cells. Planta Med. 74:245–251. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li DD, Guo JF, Huang JJ, et al:
Rhabdastrellic acid-A induced autophagy-associated cell death
through blocking Akt pathway in human cancer cells. PLoS One.
5:e121762010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kanzawa T, Zhang L, Xiao L, Germano IM,
Kondo Y and Kondo S: Arsenic trioxide induces autophagic cell death
in malignant glioma cells by upregulation of mitochondrial cell
death protein BNIP3. Oncogene. 24:980–991. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Duan WJ, Li QS, Xia MY, Tashiro S, Onodera
S and Ikejima T: Silibinin activated p53 and induced autophagic
death in human fibrosarcoma HT1080 cells via reactive oxygen
species-p38 and c-Jun N-terminal kinase pathways. Biol Pharm Bull.
34:47–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lin JF, Lin YC, Lin YH, et al: Zoledronic
acid induces autophagic cell death in human prostate cancer cells.
J Urol. 185:1490–1496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chao AC, Hsu YL, Liu CK and Kuo PL:
α-Mangostin, a dietary xanthone, induces autophagic cell death by
activating the AMP-activated protein kinase pathway in glioblastoma
cells. J Agric Food Chem. 59:2086–2096. 2011.
|
|
63
|
Puissant A, Robert G, Fenouille N, et al:
Resveratrol promotes autophagic cell death in chronic myelogenous
leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK
activation. Cancer Res. 70:1042–1052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Suh Y, Afaq F, Khan N, Johnson JJ, Khusro
FH and Mukhtar H: Fisetin induces autophagic cell death through
suppression of mTOR signaling pathway in prostate cancer cells.
Carcinogenesis. 31:1424–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xiong HY, Guo XL, Bu XX, et al: Autophagic
cell death induced by 5-FU in Bax or PUMA deficient human colon
cancer cell. Cancer Lett. 288:68–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shen S, Kepp O and Kroemer G: The end of
autophagic cell death? Autophagy. 8:1–3. 2012. View Article : Google Scholar
|
|
67
|
Shen S, Kepp O, Michaud M, et al:
Association and dissociation of autophagy, apoptosis and necrosis
by systematic chemical study. Oncogene. 30:4544–4556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li J, Qin Z and Liang Z: The prosurvival
role of autophagy in resveratrol-induced cytotoxicity in human U251
glioma cells. BMC Cancer. 9:2152009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sy LK, Yan SC, Lok CN, Man RY and Che CM:
Timosaponin A-III induces autophagy preceding mitochondria-mediated
apoptosis in HeLa cancer cells. Cancer Res. 68:10229–10237. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Huang S and Sinicrope FA:
Celecoxib-induced apoptosis is enhanced by ABT-737 and by
inhibition of autophagy in human colorectal cancer cells.
Autophagy. 6:256–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ren JH, He WS, Nong L, et al: Acquired
cisplatin resistance in human lung adenocarcinoma cells is
associated with enhanced autophagy. Cancer Biother Radiopharm.
25:75–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kroemer G and Levine B: Autophagic cell
death: the story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Galluzzi L, Vitale I, Abrams JM, et al:
Molecular definitions of cell death subroutines: recommendations of
the Nomenclature Committee on Cell Death 2012. Cell Death Differ.
19:107–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kroemer G, Marino G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Pattingre S, Bauvy C and Codogno P: Amino
acids interfere with the ERK1/2-dependent control of macroautophagy
by controlling the activation of Raf-1 in human colon cancer HT-29
cells. J Biol Chem. 278:16667–16674. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Aoki H, Takada Y, Kondo S, Sawaya R,
Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the
growth of malignant gliomas in vitro and in vivo through induction
of autophagy: role of Akt and extracellular signal-regulated kinase
signaling pathways. Mol Pharmacol. 72:29–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Goussetis DJ, Altman JK, Glaser H, McNeer
JL, Tallman MS and Platanias LC: Autophagy is a critical mechanism
for the induction of the antileukemic effects of arsenic trioxide.
J Biol Chem. 285:29989–29997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Qian W, Liu J, Jin J, Ni W and Xu W:
Arsenic trioxide induces not only apoptosis but also autophagic
cell death in leukemia cell lines via up-regulation of Beclin-1.
Leuk Res. 31:329–339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Shimizu S, Takehara T, Hikita H, et al:
Inhibition of autophagy potentiates the antitumor effect of the
multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J
Cancer. 131:548–557. 2012. View Article : Google Scholar : PubMed/NCBI
|
